Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001424

Drug Information
NameSalbutamol sulphate
Synonymsm-Xylene-alpha,alpha'-diol, alpha-((tert-butylamino)methyl)-4-hydroxy-; Salbuven; alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol; (alpha1-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha-diol); AH 3365; Ventolin Rotacaps; Albuterol [USAN]; Salbulin; Ventamol; Prestwick_665; R,S-Albuterol; KBio1_000943; UNII-QF8SVZ843E; 4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol; Salmaplon; DL-N-tert-Butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine; Ventoline; KBio2_005816; to_000081; Salbutan; Salamol; Asmaven; Salbutine; HMS2089I19; SBB066105; Grafalin; alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha -diol; KBio2_003248; Spectrum2_001350; Parasma; Albuterol hemisulfate; Prestwick1_000198; HSDB 7206; (+-)-Albuterol; Prestwick0_000198; Dilatamol; NINDS_000943; NCGC00024698-02; 1-(tert-Butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol; DB01001; Salbutalan; Aerolin; HMS1568H17; Bio1_000446; KBio2_000680; Prestwick2_000198; BCBcMAP01_000116; Farcolin; SMP1_000268; Libretin; Anebron; SPBio_002076; 4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol; Cetsim; m-Xylene-alpha,alpha'-diol, alpha'-((tert-butylamino)methyl)-4-hydroxy-; Buventol; CHEMBL714; 1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-; Ventilan; Bio1_001424; 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol; Tobybron; Asmadil; CID2083; S8260_SIGMA; Bronter; 46725_RIEDEL; Spreor; Bugonol; Respax; Sultanol; dl-Albuterol; I06-0331; ProAir; Salbupur; Ventolin Inhaler; Suxar; Butohaler; D02147; EU-0101090; NCGC00015955-11; 1,3-Benzenedimethanol, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-; 35763-26-9; 1,3-Benzenedimethanol, .alpha.(1)-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-; Asmol; NCGC00024698-03; Theosal; Solbutamol; EINECS 242-424-0; MolPort-001-838-925; Medolin; 18559-94-9; (+-)-Salbutamol; SPBio_001539; Salbutard; Broncovaleas; Butamol; VU0243312-5; dl-Salbutamol; L000531; CHEBI:2549; Albuterol (USP); Salbutamolum [INN-Latin]; MLS000758199; albuterol; Alti-Salbutamol; Salbetol; nchembio801-comp4; PDSP1_000623; Respolin; Butotal; NCGC00015955-10; Salbutamol; Salbron; AC1Q1MO0; Proventil HFA; Rotahaler; Novosalmol; Gerivent; NCGC00024698-04; Ecovent; Mozal; LS-7693; BRD-A88254928-001-04-6; Prestwick3_000198; Volma; Buto-Asma; Salbusian; AB00052154; Vencronyl; Asthalin; SGCUT00011; DivK1c_000943; racemic-Salbutamol; PDSP2_000620; IDI1_000943; Salbutamol Sulphate; Salvent; Salbutamolum; Albuterol Sulphate; Sultanol N; Salbutamol sulfate; HMS2092I08; Pneumolat; Sabutal; NCGC00024698-06; Lopac0_001098; Proventil Inhaler; BSPBio_000155; Bio1_000935; Ventalin inhaler; NCGC00024698-05; Servitamol; Cobutolin; Asmasal; HMS1921C04; Saventol; NCGC00015955-04; Salomol; Proventil; alpha'-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol; Volmax; BRN 2213614; Arubendol-Salbutamol; SPECTRUM1500677; Salbuhexal; Salbu-BASF; Almotex; Sabutamol; Asmatol; Ventiloboi; SMR000058513; 46725_FLUKA; Asthavent; Salbu-Fatol; S 8260; 2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol; NCGC00024698-07; Volare albuterol HFA; 4-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; Salbutol; Asmol Uni-Dose; ST024764; LS-29861; Airomir; KBioGR_001294; KBioSS_000680; Spectrum5_001059; Spectrum_000200; AC-10286; alpha-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha'-diol; Asmanil; Proventil (TN); Asmidon; Lopac0_001090; HMS502P05; BPBio1_000171; Broncho-Spray; Bumol; Butovent; Volare easi-breathe; Spectrum4_000887; Zaperin; AC1L1CVO; Ventodisks; Salbuvent; Sallbupp; Suprasma
IndicationAcute Asthma
[ICD9: 493   ICD10: J45]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12
,14-17H,7-8H2,1-3H3
InChIKeyNDAUXUAQIAJITI-UHFFFAOYSA-N
Canonical SMILESCC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O    
Therapeutic ClassBronchodilator Agents
CAS NumberCAS 51022-70-9
FormulaC26H42N2O10S
PubChem Compound IDCID 2083.
PubChem Substance IDSID 171517.
SuperDrug ATC IDR03AC02
R03AC02; R03CC02
TargetBeta-2 adrenergic receptorAgonist[2]
Ref 1Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Emerg Drugs. 2007 Sep;12(3):461-77. To Reference
Ref 2Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol). CNS Drugs. 2002;16(1):1-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543